The concomitant use of oxycodone HCl with all cytochrome P450 3A4 inhibitors may end in a rise in oxycodone plasma concentrations, which could boost or prolong adverse reactions and could induce most likely fatal respiratory despair. On top of that, discontinuation of the concomitantly applied cytochrome P450 3A4 inducer could https://borisp123geb2.csublogs.com/profile